2020 Interactive Breakout Discussions

We are currently building the agendas for SCOPE 2020 and the early topics and co-moderators for the breakout discussion groups are listed below. This is a preliminary list that will be updated soon. New breakout discussion topic suggestions are welcome.

Wednesday, February 19

BREAKOUT DISCUSSION GROUPS

4:20 Find Your Table and Meet Your Moderator

4:25 Interactive Breakout Discussion Groups

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion at hand. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions below. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing.

5:10 Welcome Reception in the Exhibit Hall

6:45 Close of Day


These are rough topics for the breakout discussion groups below. We will be listing the co-moderators for each table and updating this list soon…

PATIENT ENGAGEMENT AND RECRUITMENT

TABLE: Integrating Health Literacy and Cultural Sensitivity into Clinical Trials
TABLE: What Is Holding Back the Adoption of eConsent?
TABLE: Strategies for Aligning and Accelerating Recruitment in Complex Clinical Trials in a Resource Constrained Environment
TABLE: Strategies for Patient-Centric Trial Design and Digital Patient Engagement
TABLE: Operationalizing Diversity and Inclusion into Your Clinical Trials
TABLE: Shiny New Objects: Can Traditional Recruitment Mediums Merge with Technology Driven Solutions for Better Engagement?

PROTOCOL OPTIMIZATION AND TRIAL DESIGN

TABLE: Embracing Best Practices in Protocol Design to Reduce Protocol Amendments and Improve Trials
TABLE: How to Start from Scratch to Get Patient Input into Clinical Trial Design

FEASIBILITY AND SITE SELECTION

TABLE: Optimizing Country and Site Selection: Strategies for Positioning Trials for Success Using a Global Footprint
TABLE: Building and Implementing a Data-Driven Site Selection Approach

STUDY START UP AND OPERATIONS

TABLE: Ask a Site: Tips, Tricks and Trends in Site Operations, Compliance and Site-Sponsor Relationships
TABLE: Barriers and Opportunities in Site Adoption of Clinical Trial Technology
TABLE: Identifying and Alleviating Burdens Inherent in Clinical Trials (for Patients, Sites, Caregivers, Investigators and Trial Managers)
TABLE: Partnering with Qualified Investigators and Study Teams for Improved Site Performance, Efficiency, and Execution of Clinical Trials

BUDGETING, CONTRACTING AND RESOURCE MANAGEMENT

TABLE: Coordinating Contracting and Payments to Enhance Efficiencies
TABLE: Contracting Strategies and Tools for Speedy Study Start-Up
TABLE: Balancing Budgets and Performance in Resource Management and Capacity Planning
TABLE: Developing Resource Management Tools for Complex Trials and Diverse Portfolios

CLINICAL SUPPLY AND LOGISTICS

TABLE: Clinical Trial Supply Chain Strategy to Minimize Risk and Cost
TABLE: Optimizing Clinical Trial Supply Forecasting and Distribution
TABLE: Clinical Supply in Virtual Trials

OUTSOURCING

TABLE: Vendor Performance Metrics and KPIs
TABLE: Strategies for Becoming a Partner of Choice
TABLE: FSP vs. Hybrid vs. Strategic Partnership Outsourcing – Choosing an Appropriate Model

DATA AND TECHNOLOGY

TABLE: Digital Biomarkers and Endpoints in Clinical Trials
TABLE: Digital Data Transfer and Virtual Trials
TABLE: Artificial Intelligence and Machine Learning: Extreme Case of Data Analytics?
TABLE: Technologies to Enable Patient-Centered Trials
TABLE: Innovative Clinical Analytics Strategy

MONITORING AND QUALITY

TABLE: Linking Quality and RBM
TABLE: Data Visualization and Advanced Analytics for RBM
TABLE: Implementing RBM in US and Globally

RWD/RWE

TABLE: RWE to Support Regulatory Decisions: Regulatory Grade RWD
TABLE: Innovative RWD-Based Studies

BIOMARKERS AND BIOSPECIMENS

TABLE: Biomarker Data Ownership and Returning Results to Patients
TABLE: Technology to Streamline Sample Management in Clinical Trials

CHINA CLINICAL DEVELOPMENT PARTNERING

TABLE: Bringing New Therapies to Market in the West and in China: Clinical Development Partnering

MEDICAL DEVICE TRIALS

TABLE: Navigating the EU MDR
TABLE: Risk-Based Monitoring for Medical Device Trials
TABLE: Pre- Vs. Post-Market Studies for Medical Devices: Different Challenges and Strategies

OTHER/NEW TABLES: Topics to be Announced…